MKK7, the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target.
Jae Gwang ParkNur AzizYoung-Jin SonPublished in: Therapeutic advances in medical oncology (2019)
One of the mitogen-activated protein kinases (MAPKs), c-Jun NH2-terminal protein kinase (JNK) plays an important role in regulating cell fate, such as proliferation, differentiation, development, transformation, and apoptosis. Its activity is induced through the interaction of MAPK kinase kinases (MAP3Ks), MAPK kinases (MAP2Ks), and various scaffolding proteins. Because of the importance of the JNK cascade to intracellular bioactivity, many studies have been conducted to reveal its precise intracellular functions and mechanisms, but its regulatory mechanisms remain elusive. In this review, we discuss the molecular characterization, activation process, and physiological functions of mitogen-activated protein kinase kinase 7 (MKK7), the MAP2K that most specifically controls the activity of JNK. Understanding the role of MKK7/JNK signaling in physiological conditions could spark new hypotheses for targeted anticancer therapies.
Keyphrases
- signaling pathway
- protein kinase
- cell death
- induced apoptosis
- pi k akt
- oxidative stress
- endoplasmic reticulum stress
- cell fate
- cell cycle arrest
- transcription factor
- tyrosine kinase
- high density
- dna methylation
- cancer therapy
- diabetic rats
- high glucose
- genome wide
- squamous cell
- young adults
- room temperature
- endothelial cells
- drug delivery
- metal organic framework
- childhood cancer